Dashboard MRSA
Repurposing candidates for MRSA
Methicillin-resistant Staphylococcus aureus
Approved medicines with AI-predicted activity ≥40% against MRSA, leaving out medicines that are already antimicrobials. Each is shown with what it is already used for. They are surfaced computationally for further investigation, not as treatments.
- AI-predicted activity ≥40%
- 860
- Existing antimicrobials set aside
- 117
- Needing review
- 72
- Repurposing candidates
- 671
Repurposing candidates for MRSA
AI prediction · nothing measuredAll 671 repurposing candidates for MRSA.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- Baloxavir MarboxilExisting use: Influenza, Viral disease55.7% AI-predicted activityagainst MRSA24 registered studies
- Betamethasone AcetateExisting use: Airway obstruction, Anemia, Asthma and 7 more55.7% AI-predicted activityagainst MRSA27 registered studies
- BrexanoloneExisting use: Depressive disorder, Major depressive disorder, Postpartum depression55.6% AI-predicted activityagainst MRSA26 registered studies
- BetrixabanExisting use: Recurrent thrombophlebitis, Venous thromboembolism55.5% AI-predicted activityagainst MRSA14 registered studies
- NisoldipineExisting use: Cardiovascular disease, Hypertension55.4% AI-predicted activityagainst MRSA6 registered studies
- RelugolixExisting use: Metastatic prostate cancer, Neoplasm, Prostate adenocarcinoma and 1 more55.4% AI-predicted activityagainst MRSA50+ registered studies
- Trilaciclib DihydrochlorideExisting use: Small cell lung carcinoma55.4% AI-predicted activityagainst MRSA2 registered studies
- SparsentanExisting use: IGA glomerulonephritis55.4% AI-predicted activityagainst MRSA11 registered studies
- Sunitinib MalateExisting use: Cancer, Clear cell renal carcinoma, Gastrointestinal stromal tumor and 6 more55.3% AI-predicted activityagainst MRSA50+ registered studies
- Haloperidol DecanoateExisting use: Conduct disorder, Mental or behavioural disorder, Psychosis and 4 more55.3% AI-predicted activityagainst MRSA50+ registered studies
- FutibatinibExisting use: Cancer, Cholangiocarcinoma, Neoplasm55.3% AI-predicted activityagainst MRSA25 registered studies
- PrazepamExisting use: Anxiety55.3% AI-predicted activityagainst MRSANo documented evidence found
- DrospirenoneExisting use: Acne55.2% AI-predicted activityagainst MRSA50+ registered studies
- MifepristoneExisting use: Cushing syndrome55.1% AI-predicted activityagainst MRSA50+ registered studies
- SincalideExisting use: Tests for bile duct patency55.1% AI-predicted activityagainst MRSA10 registered studies
- BrigatinibExisting use: Neoplasm, Non-small cell lung carcinoma55.1% AI-predicted activityagainst MRSA48 registered studies
- Ziprasidone MesylateExisting use: Agitation, Bipolar disorder, Bipolar I disorder and 5 more55.0% AI-predicted activityagainst MRSA50+ registered studies
- Nalbuphine HydrochlorideExisting use: Pain55.0% AI-predicted activityagainst MRSA50+ registered studies
- Osimertinib MesylateExisting use: Cancer, Neoplasm, Non-small cell lung carcinoma55.0% AI-predicted activityagainst MRSA26 registered studies
- SpironolactoneExisting use: Ascites, Cardiovascular disease, Cirrhosis of liver and 10 more55.0% AI-predicted activityagainst MRSA50+ registered studies
- Fosdenopterin HydrobromideExisting use: Inborn metal metabolism disorder, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A54.9% AI-predicted activityagainst MRSANo documented evidence found
- MeprednisoneExisting use: Glucocorticoids54.9% AI-predicted activityagainst MRSA2 registered studies
- Ruxolitinib PhosphateExisting use: Alopecia areata, Cancer, Eczematoid dermatitis and 7 more54.9% AI-predicted activityagainst MRSA50+ registered studies
- EntrectinibExisting use: Cancer, Neoplasm, Non-small cell lung carcinoma54.8% AI-predicted activityagainst MRSA46 registered studies